NBP (NBP)
1.78
+0.03 (1.71%)
Upcoming Events
Latest Headlines
Form 6-K NovaBridge Biosciences For: Jul 24
July 24, 2026 5:05 PM - SEC Filing
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
July 24, 2026 5:00 PM - Globe NewsWire
Form 6-K NovaBridge Biosciences For: Jul 13
July 17, 2026 6:04 AM - SEC Filing
Form 4 NovaBridge Biosciences For: Jul 08 Filed by: Hagler Mark Arnold
July 10, 2026 5:00 PM - SEC Filing
Form 4 NovaBridge Biosciences For: Jul 08 Filed by: Lin Liwei Lorraine
July 10, 2026 5:00 PM - SEC Filing
Form 4 NovaBridge Biosciences For: Jul 06 Filed by: Gupta Srishti
July 8, 2026 4:26 PM - SEC Filing
Form 3 NovaBridge Biosciences For: Jul 01 Filed by: Gupta Srishti
July 8, 2026 4:24 PM - SEC Filing
Form 4 NovaBridge Biosciences For: Jul 04 Filed by: Xu Cong Claire
July 7, 2026 7:50 PM - SEC Filing
Form 4 NovaBridge Biosciences For: Jun 29 Filed by: Fu Wei
June 30, 2026 4:15 PM - SEC Filing
NovaBridge Biosciences names new CEO, replacing Xi-Yong Fu
June 29, 2026 7:02 AM - StreetInsider
Form 6-K NovaBridge Biosciences For: Jun 29
June 29, 2026 7:00 AM - SEC Filing
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
June 29, 2026 7:00 AM - Globe NewsWire
Form 4 NovaBridge Biosciences For: Jun 22 Filed by: Cao Sean Wuxiong
June 24, 2026 7:22 PM - SEC Filing
Form 4 NovaBridge Biosciences For: Jun 17 Filed by: Dennis Phillip Andrew
June 22, 2026 5:24 PM - SEC Filing
Form 20-F/A NovaBridge Biosciences For: Dec 31
June 16, 2026 4:45 PM - SEC Filing
Form 6-K NovaBridge Biosciences For: Jun 16
June 16, 2026 4:40 PM - SEC Filing
FDA grants fast track status to NOVABRIDGE drug for gastric cancer
June 16, 2026 7:00 AM - StreetInsider
NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer
June 16, 2026 7:00 AM - Globe NewsWire
Form 6-K NovaBridge Biosciences For: Jun 16
June 16, 2026 7:00 AM - SEC Filing
Form 4 NovaBridge Biosciences For: May 30 Filed by: Xu Cong Claire
June 2, 2026 6:47 PM - SEC Filing
NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026 7:00 AM - Globe NewsWire
Form 4 NovaBridge Biosciences For: May 14 Filed by: Cao Sean Wuxiong
May 18, 2026 4:05 PM - SEC Filing
Form 144 NovaBridge Biosciences Filed by: Cao Sean Wuxiong
May 14, 2026 2:51 PM - SEC Filing
NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
May 12, 2026 7:00 AM - Globe NewsWire
Full Article List